I just want the world to be a much better place for our children. Too long have we allowed the wicked to be in control. Time to take control back and save us.
@Deenresponds - Auzu billahi minash shaitanir rajim. You are spreading hate against a woman who has single-handedly promoted Islam to another level and made a lot of people convert to Islam. Again. Auzu billahi minash shaitanir rajim. You are evil, and evil will not win.
@Deenresponds - Auzu billahi minash shaitanir rajim. You are spreading hate against a woman who has single-handedly promoted Islam to another level and made a lot of people convert to Islam. Again. Auzu billahi minash shaitanir rajim. You are evil, and evil will not win.
@Archetypical20 - Auzu billahi minash shaitanir rajim. You are spreading hate against a woman who has single-handedly promoted Islam to another level and made a lot of people convert to Islam. Again. Auzu billahi minash shaitanir rajim. You are evil, and evil will not win.
@Deenresponds - Auzu billahi minash shaitanir rajim. You are spreading hate against a woman who has single-handedly promoted Islam to another level and made a lot of people convert to Islam. Again. Auzu billahi minash shaitanir rajim. You are evil, and evil will not win.
@Deenresponds - Auzu billahi minash shaitanir rajim. You are spreading hate against a woman who has single-handedly promoted Islam to another level and made a lot of people convert to Islam. Again. Auzu billahi minash shaitanir rajim. You are evil, and evil will not win.
@CanyonMimbs - Auzu billahi minash shaitanir rajim. You are spreading hate against a woman who has single-handedly promoted Islam to another level and made a lot of people convert to Islam. Again. Auzu billahi minash shaitanir rajim. You are evil, and evil will not win.
@5Pillarsuk - Auzu billahi minash shaitanir rajim. You are spreading hate against a woman who has single-handedly promoted Islam to another level and made a lot of people convert to Islam. Again. Auzu billahi minash shaitanir rajim. You are evil, and evil will not win.
@RmSalih - Auzu billahi minash shaitanir rajim. You are spreading hate against a woman who has single-handedly promoted Islam to another level and made a lot of people convert to Islam. Again. Auzu billahi minash shaitanir rajim. You are evil, and evil will not win.
@RmSalih@lilyjayofficial - Auzu billahi minash shaitanir rajim. You are spreading hate against a woman who has single-handedly promoted Islam to another level and made a lot of people convert to Islam. Again. Auzu billahi minash shaitanir rajim. You are evil, and evil will not win.
@Jay_49erTikTok - Auzu billahi minash shaitanir rajim. You are spreading hate against a woman who has single-handedly promoted Islam to another level and made a lot of people convert to Islam. Again. Auzu billahi minash shaitanir rajim. You are evil, and evil will not win.
@5Pillarsuk - Auzu billahi minash shaitanir rajim. You are spreading hate against a woman who has single-handedly promoted Islam to another level and made a lot of people convert to Islam. Again. Auzu billahi minash shaitanir rajim. You are evil, and evil will not win.
@Farid_0v FARID - auzu billahi minash shaitanir rajim.
You are spreading hate against a woman who has single-handedly promoted Islam to another level and made a lot of people convert to Islam. Again. Auzu billahi minash shaitanir rajim. You are evil, and evil will not win.
#VAL@valirxplc 💪
in-licensing, IP portfolio expansion, preclinical development and expansion of ValiRx Animal Health
🔷6-7 figure grant update
🔷 Cytolytik update
🔷 VAL401 update
🔷University of Dundee Project
🔷PredictRx®️ Clinical Validation
🔷VAL201/ Blue Ribbon Biotech
🔷TwinEdge Avatar Platform Progress
🔷Dominion 3k drug repurposing
Mark Eccleston, CEO, commented:
We believe the combination of Cytolytix, the McGill opportunity, our growing companion animal health activities and continued development of our translational capabilities creates multiple opportunities for value creation over the coming 12 months.
"Importantly, we continue to focus on a capital-efficient model built around licensing, partnerships, SPVs and non-dilutive funding opportunities, rather than relying solely on traditional high-cost biotech development pathways.
"We believe the current valuation does not fully reflect the breadth of assets, intellectual property and commercial optionality within the Group
£2m Market Cap
£1.15m Cash
Potential upside in multiples 💼 💼 💼
#VAL@valirxplc
Avalanche of news coming including
in-licensing, IP portfolio expansion, preclinical development and expansion of ValiRx Animal Health
🔷6-7 figure grant update
🔷 Cytolytik update
🔷 VAL401 update
🔷University of Dundee Project
🔷PredictRx®️ Clinical Validation
🔷VAL201/ Blue Ribbon Biotech
🔷TwinEdge Avatar Platform Progress
🔷Dominion 3k drug repurposing
Mark Eccleston, CEO, commented:
We believe the combination of Cytolytix, the McGill opportunity, our growing companion animal health activities and continued development of our translational capabilities creates multiple opportunities for value creation over the coming 12 months.
"Importantly, we continue to focus on a capital-efficient model built around licensing, partnerships, SPVs and non-dilutive funding opportunities, rather than relying solely on traditional high-cost biotech development pathways.
"We believe the current valuation does not fully reflect the breadth of assets, intellectual property and commercial optionality within the Group
£2m Market Cap
£1.15m Cash
Potential upside in multiples
@AfzalValli ✅ Companion animal rights expected to be cross-licensed into ValiRx Animal Health
Not a licensing deal yet, but a clear step from evaluation towards commercialisation. Interesting progress for a company with a ~£2m market cap.
#AIM#Biotech
@AfzalValli $VAL #VAL
Strong update from ValiRx.
✅ McGill/IRICoR evaluation completed 4 months early
✅ VAL has exercised its option to negotiate an exclusive licence
✅ NewCo formation progressing
✅ Discussions with potential investors have advanced to due diligence